Ambeed.cn

首页 / / / Calcium Channel / Benidipine HCl/贝尼地平盐酸盐

Benidipine HCl/贝尼地平盐酸盐 {[allProObj[0].p_purity_real_show]}

货号:A214046 同义名: 盐酸贝尼地平 / KW-3049; Benidipine (hydrochloride)

Benidipine HCl 是一种二氢吡啶类钙通道拮抗剂,兼具抗氧化特性,可改善高血压大鼠冠状动脉循环,常用于高血压研究。

Benidipine HCl/贝尼地平盐酸盐 化学结构 CAS号:91599-74-5
Benidipine HCl/贝尼地平盐酸盐 化学结构
CAS号:91599-74-5
Benidipine HCl/贝尼地平盐酸盐 3D分子结构
CAS号:91599-74-5
Benidipine HCl/贝尼地平盐酸盐 化学结构 CAS号:91599-74-5
Benidipine HCl/贝尼地平盐酸盐 3D分子结构 CAS号:91599-74-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Benidipine HCl/贝尼地平盐酸盐 纯度/质量文件 产品仅供科研

货号:A214046 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Ca2+ channel-like protein Calcium Channel Cav 2.2 其他靶点 纯度
CDC25B-IN-2 Akt 99%+
Clevidipine 97%
Verapamil HCl 99%
Amlodipine 99%
Amlodipine maleate 98%
(+)-cis-Diltiazem HCl 99%
Zegocractin ++

Orai1/STIM1-mediated Ca2+ currents, IC50: 120 nM

99%+
Tanshinone IIA sulfonate sodium 98%
Ulixacaltamide ++

hCaV3.2, IC50: 110 nM

hCaV3.1, IC50: 50 nM

99%+
Dronedarone HCl 95%
Nitrendipine +

Calcium channel, IC50: 95 nM

98%
Efonidipine HCl monoethanolate 98%
Cinnarizine 98%
SEA0400 ++

NCX, IC50: 33 nM

ROS,ERK,p38 MAPK 99%+
Fasudil HCl Rho,PKA 98%
ML-9 MLCK,Akt 99%+
Flunarizine 2HCl +

Calcium channel, Ki: 68 nM

95%
Lomerizine 2HCl 98%
Efonidipine 98%
Levamlodipine 98%
Nisoldipine ++

L-type Cav1.2, IC50: 10 nM

97%
Isradipine 98%
Lacidipine 98%
Lercanidipine 99%
Loureirin B Potassium Channel 99%+
Tetracaine HCl 98%
Manidipine +++

Calcium channel, IC50: 2.6 nM

99%
Manidipine Dihydrochlorid +++

Calcium channel, IC50: 2.6 nM

98%
Nicardipine 99%
Wilforgine 98+%
Econazole 99%+
Ginsenoside Rd NF-κB 98%
Fendiline HCl 98+%
Mesaconitine 98%
Tetrandrine 95%
Nifedipine 98%
Nilvadipine ++++

Calcium channel, IC50: 0.03 nM

95%
Barnidipine ++++

[3H]nitrendipine, Ki: 0.21 nM

95+%
Azelnidipine 97%
Levetiracetam 98%
Nimodipine 95%
Benidipine HCl 98%
Pinaverium bromide 98%
Pranidipine 99%
NP118809 +

N-type Ca2+ channel, IC50: 0.11 μM

L-type calcium channel, IC50: 12.2 μM

95%
Amlodipine Besylate +++

Calcium channel, IC50: 1.9 nM

97%
Cilnidipine 99%
Cinepazide Maleate 99% (HPLC)
Terfenadine 98%
YM-58483 99%+
Amiloride HCl 98%
Ranolazine 98%
Praeruptorin A p38 MAPK,Akt 98%
Ranolazine 2HCl 98%
Felodipine ++++

L-type calcium channel, IC50: 0.15 nM

98%
PD173212 +++

N-type Ca2+ channel, IC50: 36 nM

98%
Levamlodipine besylate 97%
Carboxyamidotriazole Orotate 98%
IGS-1.76 98+%
WH-4-023 ++++

Cav 2.2, IC50: 0.001 μM

++++

Cav 2.2, IC50: 0.001 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Benidipine HCl/贝尼地平盐酸盐 生物活性

靶点
  • Calcium Channel

描述 Benidipine hydrochloride, a calcium channel blocker (CCB), inhibited SFTSV (Severe fever with thrombocytopenia syndrome virus) replication in vitro. Benidipine hydrochloride was revealed to inhibit virus infection through impairing virus internalization and genome replication[3]. Histopathologically neuroprotective effects of benidipine hydrochloride was seen in the cerebral cortex tissues. Benidipine hydrochloride can play a certain protective role in the cerebral I/R injury. The protective effect of this agent may be related to the improvement on the antioxidant capacity of brain tissue and the inhibition of overproduction of inflammatory cytokines[4]. Moreover, patients with hypertension have high plasma TBARS (thiobarbituric acid reactive substance), and benidipine hydrochloride decreases not only blood pressure but also oxidative stress in the clinical practice[5]. Benidipine has a more potent antihypertensive effect than cilnidipine and also a renoprotective effect, indicating the high usefulness of benidipine in hypertensive patients with diabetes[6]. Combination therapy with benidipine hydrochloride and candesartan cilexetil may contribute to the suppression of arteriosclerosis and may be useful for elderly hypertensive patients with diabetes mellitus[7].

Benidipine HCl/贝尼地平盐酸盐 细胞实验

Cell Line
Concentration Treated Time Description References
GE1 cells 1, 10, 100, 1000, 10000 nM 12 hours Promoted GE1 cell proliferation Adv Wound Care (New Rochelle). 2019 Mar 1;8(3):108-117.
MC3T3-E1 cells 0.01, 0.10, 1.00 µM 21 days To evaluate the effect of Benidipine on matrix mineralization in MC3T3-E1 cells, results showed that Benidipine significantly promoted extracellular matrix mineralization. J Zhejiang Univ Sci B. 2021 May 15;22(5):410-420.
MLO-Y4 cells 0.1, 1, 10, 100, 1000, 10000 nM 24 hours Promoted MLO-Y4 cell proliferation Adv Wound Care (New Rochelle). 2019 Mar 1;8(3):108-117.
Huh7 cells 10 µM 24 hours Benidipine HCl significantly inhibited HTNV replication in Huh7 cells Front Pharmacol. 2022 Aug 29;13:940178.
A549 cells 6.552 µM 24 hours Benidipine HCl significantly inhibited HTNV replication in A549 cells with an IC50 of 6.552 μM Front Pharmacol. 2022 Aug 29;13:940178.
Rat aortic endothelial cells 10 nM 30 minutes To investigate the effects of benidipine on LPC-induced suppression of [Ca2+]i increase in endothelial cells, results showed that benidipine inhibited LPC-induced suppression of [Ca2+]i increase J Biomed Sci. 2009 Jun 26;16(1):57.
Vero cells 10 µM 36 hours Benidipine hydrochloride showed the strongest inhibitory effect on SFTSV infection (>90%) at the concentration of 10 μM. Cell Res. 2019 Sep;29(9):739-753.
HEK293T cells 1 µM 40 minutes To investigate the inhibitory mechanism of Benidipine on CaV1.2 channels, cryo-EM structural analysis revealed that Benidipine is located in the DIII-DIV fenestration site, and its hydrophobic sidechain provides additional interactions with the channel subunit α1, supporting its inhibitory effects on both L-type and T-type voltage-gated calcium channels Nat Commun. 2024 Mar 30;15(1):2772.
MC3T3-E1 cells 0.01, 0.10, 1.00 µM 48 hours To evaluate the effect of Benidipine on the proliferation of MC3T3-E1 cells, results showed that Benidipine significantly promoted cell proliferation in a dose-dependent manner. J Zhejiang Univ Sci B. 2021 May 15;22(5):410-420.
MC3T3-E1 cells 0.01, 0.10, 1.00 µM 7, 10, 14 days To evaluate the effect of Benidipine on alkaline phosphatase (ALP) activity in MC3T3-E1 cells, results showed that Benidipine significantly increased ALP activity, especially at 10 and 14 days. J Zhejiang Univ Sci B. 2021 May 15;22(5):410-420.
MRC5 normal human fibroblasts 10 µM Benidipine selectively promotes the death of cigarette smoke-induced senescent lung cells Aging (Albany NY). 2023 Dec 12;15(23):13581-13592.

Benidipine HCl/贝尼地平盐酸盐 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats MRONJ-like lesion model Local injection 0.13 mg/kg, 1.3 mg/kg Single injection, lasting two weeks Promote healing of MRONJ-like lesions, reduce necrotic bone area, and promote new bone formation Pharmaceuticals (Basel). 2022 Aug 18;15(8):1020
Sprague-Dawley rats Myocardial ischemia/reperfusion model Intravenous injection 10 mg/kg Single dose, 10 minutes before reperfusion Benidipine exerts its antiapoptotic effect by inhibiting the mitochondrial-mediated apoptotic pathway (but not the death receptor-mediated pathway), reducing myocardial apoptosis. Specifically, it decreased TUNEL-positive staining (8.4±1.2% vs 15.3±1.3%), reduced caspase-3 activity (1.94±0.25 vs 3.43±0.29), and inhibited mitochondrial cytochrome c release and caspase-9 activation. Additionally, benidipine enhanced ERK1/2 activity and prolonged its activation duration but had no significant effect on p38 MAPK. Br J Pharmacol. 2004 Jun;142(4):627-34
C57BL/6 mice SFTSV infection model Intragastric administration 15 mg/kg Twice a day for 7 days Benidipine hydrochloride and nifedipine significantly reduced viral loads in spleen and serum, and alleviated SFTSV-induced pathogenesis. Cell Res. 2019 Sep;29(9):739-753.
Rats Tooth extraction socket model Local injection 15 or 45 μg/kg Single injection, lasting 28 days Evaluated the effect of BD on bone and gingival healing at the extraction socket. Results showed BD significantly augmented bone volume and density, and also promoted epithelial wound healing. Adv Wound Care (New Rochelle). 2019 Mar 1;8(3):108-117.
New Zealand white rabbits Myocardial ischemia/reperfusion model Intravenous injection 3 mg/kg or 10 mg/kg Single dose, observed for 4 hours and 45 minutes To investigate the effects of benidipine on myocardial infarct size, apoptosis, necrosis, and cardiac functional recovery in rabbits subjected to myocardial ischemia/reperfusion. Results showed that 10 mg/kg benidipine significantly reduced myocardial apoptosis (6.2 ±0.8% vs 12.2 ±1.1%), necrosis, and infarct size (20 ±2.3% vs 49 ±2.6%), and improved cardiac functional recovery. 3 mg/kg benidipine, without hemodynamic effects, still significantly reduced apoptosis but failed to reduce necrosis. Br J Pharmacol. 2001 Feb;132(4):869-78
Sprague-Dawley rats Sprague-Dawley rats Oral 4 mg/kg Single dose, aortas were isolated 90 minutes after administration To investigate the protective effects of benidipine on LPC-induced impairment of endothelium-dependent relaxation, results showed that benidipine inhibited LPC-induced endothelial dysfunction J Biomed Sci. 2009 Jun 26;16(1):57.

Benidipine HCl/贝尼地平盐酸盐 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00135551 Cardiovascular Disease Phase 4 Completed - Japan ... 展开 >> Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan, 755-8505 收起 <<
NCT02646397 Chronic Kidney Disease Phase 4 Unknown December 2017 China, Shanghai ... 展开 >> Department of Nephrology, Shanghai Changzheng Hospital Shanghai, Shanghai, China, 200003 收起 <<

Benidipine HCl/贝尼地平盐酸盐 参考文献

[1]Choi NY, Choi H, et al. Neuroprotective effects of amlodipine besylate and benidipine hydrochloride on oxidative stress-injured neural stem cells. Brain Res. 2014 Mar 10;1551:1-12.

[2]Higo K, Karasawa A, et al. Protective effects of benidipine hydrochloride(KW-3049), a calcium antagonist, against experimental arterial calcinosis and endothelial dysfunction in rats. J Pharmacobiodyn. 1992 Mar;15(3):113-20.

[3]Li H, Zhang LK, Li SF, et al. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res. 2019;29(9):739‐753

[4]Çakir T, Yücetaş ŞC, Yazici GN, Sunar M, Arslan YK, Süleyman H. Effects of Benidipine Hydrochloride on Ischemia/Reperfusion-Induced Inflammatory and Oxidative Brain İnjury in Rats [published online ahead of print, 2019 Sep 23]. Turk Neurosurg. 2019;10.5137/1019-5149.JTN.27372-19.3

[5]Suzuki O, Yoshida T, Tani S, et al. Antioxidative effects of benidipine hydrochloride in patients with hypertension independent of antihypertensive effects. Relationship between blood pressure and oxidative stress. Arzneimittelforschung. 2004;54(9):505‐512

[6]Seino H, Miyaguchi S, Yamazaki T, Ota S, Yabe R, Suzuki S. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine. Arzneimittelforschung. 2007;57(8):526‐531

[7]Sasaki H, Kanai S, Oyama T, Miyashita Y, Yamamura S, Shirai K. Effect of combination therapy of benidipine hydrochloride and candesartan cilexetil on serum lipid metabolism and blood pressure in elderly hypertensive patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2006;13(3):149‐157

Benidipine HCl/贝尼地平盐酸盐 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.84mL

0.37mL

0.18mL

9.22mL

1.84mL

0.92mL

18.45mL

3.69mL

1.84mL

Benidipine HCl/贝尼地平盐酸盐 技术信息

CAS号91599-74-5
分子式C28H32ClN3O6
分子量 542.02
SMILES Code O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)O[C@H]3CN(CC4=CC=CC=C4)CCC3.[H]Cl
MDL No. MFCD06407650
别名 盐酸贝尼地平 ;KW-3049; Benidipine (hydrochloride); (±)-Benidipine; Benidipine hydrochloride
运输蓝冰
InChI Key KILKDKRQBYMKQX-MIPPOABVSA-N
Pubchem ID 656667
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, store in freezer, under -20°C

溶解方案

DMSO: 35 mg/mL(64.57 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。